These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

206 related items for PubMed ID: 8194162

  • 21. Enhancement of adriamycin-induced cytotoxicity by increasing retention and inhibition of DNA repair in DOX-resistant P388 cell lines with new calcium channel blocker, DMDP.
    Bankusli I, Yin MB, Mazzoni A, Abdellah AJ, Rustum YM.
    Anticancer Res; 1989; 9(3):567-74. PubMed ID: 2764503
    [Abstract] [Full Text] [Related]

  • 22. [The in vitro cytotoxicity and in vivo toxicity of doxorubicin antiresistant stealth liposomes].
    Wang JC, Liu XY, Lü WL, Lee HS, Goh BC, Zhang Q.
    Yao Xue Xue Bao; 2005 May; 40(5):475-80. PubMed ID: 16220797
    [Abstract] [Full Text] [Related]

  • 23. Partial synergism between dextran-conjugated doxorubicin and cancer drugs on the killing of multidrug resistant KB-V1 cells.
    Fong WF, Lam W, Yang M, Wong JT.
    Anticancer Res; 1996 May; 16(6B):3773-8. PubMed ID: 9042256
    [Abstract] [Full Text] [Related]

  • 24. Intrinsic cytotoxicity and reversal of multidrug-resistance by monensin in kb parent and mdr cells.
    Ling Y, Priebe W, Perezsoler R.
    Int J Oncol; 1993 Nov; 3(5):971-7. PubMed ID: 21573461
    [Abstract] [Full Text] [Related]

  • 25. Calmodulin inhibitor trifluoperazine in combination with doxorubicin induces the selection of tumour cells with the multidrug resistant phenotype.
    Kamath N, Grabowski D, Ford J, Ganapathi R.
    Br J Cancer; 1993 Jun; 67(6):1203-8. PubMed ID: 8099806
    [Abstract] [Full Text] [Related]

  • 26. Effects of liposome-entrapped annamycin in human breast cancer cells: interference with cell cycle progression and induction of apoptosis.
    Orlandi L, Bertoli G, Abolafio G, Daidone MG, Zaffaroni N.
    J Cell Biochem; 2001 Jun; 81(1):9-22. PubMed ID: 11180394
    [Abstract] [Full Text] [Related]

  • 27. Increased intracellular drug accumulation and complete chemosensitization achieved in multidrug-resistant solid tumors by co-administering valspodar (PSC 833) with sterically stabilized liposomal doxorubicin.
    Krishna R, St-Louis M, Mayer LD.
    Int J Cancer; 2000 Jan 01; 85(1):131-41. PubMed ID: 10585596
    [Abstract] [Full Text] [Related]

  • 28. Codelivery of Doxorubicin and Verapamil for Treating Multidrug Resistant Cancer Cells.
    Williams JB, Buchanan CM, Pitt WG.
    Pharm Nanotechnol; 2018 Jan 01; 6(2):116-123. PubMed ID: 30207210
    [Abstract] [Full Text] [Related]

  • 29. Pegylated phosphotidylethanolamine inhibiting P-glycoprotein expression and enhancing retention of doxorubicin in MCF7/ADR cells.
    Wang J, Qu H, Jin L, Zeng W, Qin L, Zhang F, Wei X, Lu W, Zhang C, Liang W.
    J Pharm Sci; 2011 Jun 01; 100(6):2267-77. PubMed ID: 21246559
    [Abstract] [Full Text] [Related]

  • 30. Differential single- versus double-strand DNA breakage produced by doxorubicin and its morpholinyl analogues.
    Duran GE, Lau DH, Lewis AD, Kühl JS, Bämmler TK, Sikic BI.
    Cancer Chemother Pharmacol; 1996 Jun 01; 38(3):210-6. PubMed ID: 8646794
    [Abstract] [Full Text] [Related]

  • 31. Anthracycline-induced DNA breaks and resealing in doxorubicin-resistant murine leukemic P388 cells.
    Maniar N, Krishan A, Israel M, Samy TS.
    Biochem Pharmacol; 1988 May 01; 37(9):1763-72. PubMed ID: 2837239
    [Abstract] [Full Text] [Related]

  • 32. Mechanisms of the in vivo resistance to adriamycin and modulation by calcium channel blockers in mice.
    Yin MB, Bankusli I, Rustum YM.
    Cancer Res; 1989 Sep 01; 49(17):4729-33. PubMed ID: 2758408
    [Abstract] [Full Text] [Related]

  • 33. Lipoic acid-derived cross-linked liposomes for reduction-responsive delivery of anticancer drug.
    Ling L, Ismail M, Du Y, Yao C, Li X.
    Int J Pharm; 2019 Apr 05; 560():246-260. PubMed ID: 30769133
    [Abstract] [Full Text] [Related]

  • 34. Transferrin as a drug carrier: Cytotoxicity, cellular uptake and transport kinetics of doxorubicin transferrin conjugate in the human leukemia cells.
    Szwed M, Matusiak A, Laroche-Clary A, Robert J, Marszalek I, Jozwiak Z.
    Toxicol In Vitro; 2014 Mar 05; 28(2):187-97. PubMed ID: 24055890
    [Abstract] [Full Text] [Related]

  • 35. Nuclear delivery of doxorubicin via folate-targeted liposomes with bypass of multidrug-resistance efflux pump.
    Goren D, Horowitz AT, Tzemach D, Tarshish M, Zalipsky S, Gabizon A.
    Clin Cancer Res; 2000 May 05; 6(5):1949-57. PubMed ID: 10815920
    [Abstract] [Full Text] [Related]

  • 36. Transport mechanism of anthracycline derivatives in human leukemia cell lines: uptake and efflux of pirarubicin in HL60 and pirarubicin-resistant HL60 cells.
    Nagasawa K, Natazuka T, Chihara K, Kitazawa F, Tsumura A, Takara K, Nomiyama M, Ohnishi N, Yokoyama T.
    Cancer Chemother Pharmacol; 1996 May 05; 37(4):297-304. PubMed ID: 8548874
    [Abstract] [Full Text] [Related]

  • 37. Cross resistance relevance of the chemical structure of different anthracyclines in multidrug resistant cells.
    Tapiero H, Nguyen-Ba G, Lampidis TJ.
    Pathol Biol (Paris); 1994 Apr 05; 42(4):328-37. PubMed ID: 7808786
    [Abstract] [Full Text] [Related]

  • 38. Removal of the basic center from doxorubicin partially overcomes multidrug resistance and decreases cardiotoxicity.
    Priebe W, Van NT, Burke TG, Perez-Soler R.
    Anticancer Drugs; 1993 Feb 05; 4(1):37-48. PubMed ID: 8457713
    [Abstract] [Full Text] [Related]

  • 39. Doxorubicin encapsulated in sterically stabilized liposomes for the treatment of a brain tumor model: biodistribution and therapeutic efficacy.
    Siegal T, Horowitz A, Gabizon A.
    J Neurosurg; 1995 Dec 05; 83(6):1029-37. PubMed ID: 7490617
    [Abstract] [Full Text] [Related]

  • 40. A comparative study of folate receptor-targeted doxorubicin delivery systems: dosing regimens and therapeutic index.
    Scomparin A, Salmaso S, Eldar-Boock A, Ben-Shushan D, Ferber S, Tiram G, Shmeeda H, Landa-Rouben N, Leor J, Caliceti P, Gabizon A, Satchi-Fainaro R.
    J Control Release; 2015 Jun 28; 208():106-20. PubMed ID: 25869964
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 11.